Seventy-five percent of physicians reported that reviewing a concise clinical summary generated by the AI helped them prepare for patient visits more effectively than traditional methods. This striking statistic emerges from a recent clinical trial conducted by researchers at Harvard Medical School
The recent events at the Irkutsk Anti-Plague Research Institute demonstrate the significant challenges of managing public perception during a potential highly virulent disease outbreak. When Darya Shipilova, a 27-year-old laboratory specialist, passed away on October 2, the localized incident
A fourteen-year prison sentence for a Cushing resident serves as a stark warning to those using sham telehealth visits to drive fraudulent medical claims. This legal outcome stems from an elaborate scheme that manipulated the digital healthcare landscape, leading to over thirty million dollars in
Recent clinical data suggests that the precision of AKIR001 in targeting CD44v6 could revolutionize treatment protocols for patients with advanced thyroid malignancies. This development arrives at a critical juncture for oncology, where traditional therapies often fall short against the sheer
The transition of follow-up care from intensive monthly screenings to simple annual questionnaires illustrates the long-term stability achieved by modern transplant survivors. This remarkable shift is personified by Andrew Ruane, whose survival story bridges the primitive era of oncology and the
A collaborative partnership model between a sponsor and a midsize contract research organization facilitates the rapid adjustment of resources whenever a trial design needs to change or a new indication is added. This flexibility is essential in the current clinical development landscape of 2026,
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73
